PORTLAND, Ore. — The Oregon Health and Science University released a groundbreaking study which reveals switching arms for multi-dose COVID-19 vaccinations can boost immune response. The new study ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.

FRANKFURT, Feb 19 (Reuters) - The European Union's healthcare regulator will this week review the use of Eli Lilly's LLY.N approved Mounjaro drug against diabetes and obesity when prefilled in a multi ...

Seattle, United States & Seoul, Republic of Korea—PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi ...

FILE PHOTO: A drone view shows the Eli Lilly logo on one of the company’s offices in San Diego, California, U.S., November 21, 2025. REUTERS/Mike Blake/File Photo/File Photo Feb 23 (Reuters) - Eli ...

Clinical Trial in Africa Finds Single-Dose Malaria Treatment Combining Four Existing Drugs as Effective as More Onerous Multi-Day, Multi-Dose Regimen Research advance from Gabon presented at the ...

The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.